Sedaplus
Sedaplus, licence 80022714: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Thorne Research, Inc.
- NPN or DIN-HM
- 80022714
- Status
- Active licence
- Licence date
- 8 December 2010
- Revision date
- 22 September 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rhodiola rosea Source : Racine Potency : 3.0 % Rosavins | 25.0 mg | Not calculated |
| Valeriana officinalis Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 800 mg | 200.0 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50.0 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 1.0 % Salidrosides | Not specified | Not calculated |
| Passiflora incarnata Source : Parties aériennes Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, L-leucine, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to promote sleep / used as a sleep aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80022714
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.